Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Van der Elst, J.
Right arrow Articles by Van Steirteghem, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van der Elst, J.
Right arrow Articles by Van Steirteghem, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 11, No. 10, pp. 2097-2106, 1996
© 1996 European Society of Human Reproduction and Embryology

research-article

Endocrinology: Long-term evaluation of implantation of fresh and cryopreserved human embryos following ovarian stimulation with buserelin acetate-human menopausal gonadotrophin (HMG) or clomiphene citrate-HMG

Josiane Van der Elst1, Etienne Van den Abbeel, Michel Camus, Johan Smitz, Paul Devroey and André Van Steirteghem

Centre for Reproductive Medicine, Brussels Free University Hospital Laarbeeklaan 101, 1090 Brussels, Belgium

Correspondence: 1To whom correspondence should be addressed

This study is a long-term evaluation of the total pregnancy potential of cohorts of fresh and cryopreserved sibling embryos from in-vitro fertilization (TVF) cycles stimulated with either the gonadotrophin-releasing hormone analogue buserelin (BUS) (long protocol) or clomiphene citrate (CC) both in combination with human menopausal gonadotrophin (HMG). Therefore a retrospective analysis was performed on patients who entered the FVT programme between January 1986 and July 1987 and who had triple embryo transfer in the collection cycle. Significantly more fertilized oocytes developed to good-quality embryos in the CC-HMG group (86.1%) than in the BUS-HMG group (80.8%). Transfer of the three morphologically best-looking embryos was performed on day 2 post-insemination in 106 CC-HMG and 80 BUS-HMG cycles. Supernumerary embryos were cultured for a further 24 h and multicellular embryos with up to 20% of fragments were frozen slowly with 1.5 M dimethylsulphoxide on day 3 post-insemination (162 embryos in CC-HMG cycles, 102 embryos in BUS-HMG cycles). Outcome was measured by embryo survival rate, embryo implantation rate and delivery rate in fresh and frozen embryo transfers. Delivery rates were 31.3 and 21.7% per fresh embryo transfer in BUS-HMG and CC-HMG cycles respectively. Fresh embryo implantation rates were significantly higher in collection cycles stimulated with BUS-HMG (17.9%) than in cycles stimulated with CC-HMG (113%). Implantation rates were significantly enhanced in embryos transferred in excess of one in cycles leading to pregnancy, perhaps indicative of higher embryo quality in BUS-HMG cycles. Almost all cryopreserved embryos have by now been thawed, so the contribution of frozen embryos to overall pregnancy rates can be evaluated. Overall morphological survival rates of frozen-thawed embryos were similar for 140 embryos from CC-HMG cycles (50%) and 100 embryos from BUS-HMG cycles (46%). The percentage of fully intact embryos was, however, significantly lower in the BUS-HMG group (19%) than in the CC-HMG group (39.5%). Delivery rates were significantly lower following 30 transfers of frozen-thawed embryos from BUS-HMG-stimulated cycles (3.3%) than following 42 transfers of frozen-thawed embryos from CC-HMG cycles (19.1%). Embryo implantation rates were lower for frozen-thawed embryos from BUS-HMG cycles (23%) than from CC-HMG cycles (12.7%). Here we demonstrate that ovarian stimulation with the long protocol BUS-HMG instead of the CC-HMG protocol led to higher embryo implantation rates in collection cycles but to lower intact embryo survival rates and to lower embryo implantation rates for frozen sibling embryos. Despite the lower implantation rates with frozen embryos originating from the BUS-HMG protocol, there was no significant difference between total delivery rate per transfer from cycles stimulated with CC-HMG (30.2%) compared with BUS-HMG (33.8%).

Key words: buserelin/clomiphene citrate/embryo cryopreservation/GnRH agonists/implantation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
A. Salumets, T. Tuuri, S. Makinen, S. Vilska, L. Husu, R. Tainio, and A.-M. Suikkari
Effect of developmental stage of embryo at freezing on pregnancy outcome of frozen-thawed embryo transfer
Hum. Reprod., September 1, 2003; 18(9): 1890 - 1895.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
F. Guerif, R. Bidault, V. Cadoret, M.-L. Couet, J. Lansac, and D. Royere
Parameters guiding selection of best embryos for transfer after cryopreservation: a reappraisal
Hum. Reprod., May 1, 2002; 17(5): 1321 - 1326.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
D.A. Briggs, D.J. Sharp, D. Miller, and R.G. Gosden
Transferrin in the developing ovarian follicle: evidence for de-novo expression by granulosa cells
Mol. Hum. Reprod., December 1, 1999; 5(12): 1107 - 1114.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
R. Giess, I. Tanasescu, T. Steck, and M. Sendtner
Leukaemia inhibitory factor gene mutations in infertile women
Mol. Hum. Reprod., June 1, 1999; 5(6): 581 - 586.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.